These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 6650384)
21. Use of auxiliary labels to improve patient compliance. Fedder DO; Goldstein M; Manes T; Benko JE; Shangraw R Contemp Pharm Pract; 1979; 2(2):51-5. PubMed ID: 10241637 [No Abstract] [Full Text] [Related]
22. Commitments for tomorrow in pharmacy education: two professional degree programs. Walton CA; Doluisio JT Am J Pharm Educ; 1975 Nov; 39(4):418-24. PubMed ID: 10237145 [No Abstract] [Full Text] [Related]
28. Drug labeling and promotion: evolution and application of regulatory policy. Hayes TA Food Drug Law J; 1996; 51(1):57-73. PubMed ID: 11794353 [No Abstract] [Full Text] [Related]
35. Estrogen PPIs. An FDA survey. Morris LA; Myers A; Gibbs P; Lao C Am Pharm; 1980 Jun; NS20(6):22-6. PubMed ID: 7395715 [No Abstract] [Full Text] [Related]
36. Patient package inserts: a research perspective. Morris LA; Groft SC Drug Ther; 1982; ():191-217. PubMed ID: 7105993 [No Abstract] [Full Text] [Related]
37. Institutional pharmacists' guide to complying with PPI regulations. Greenberg RB Am J Hosp Pharm; 1980 Dec; 37(12):1656-9. PubMed ID: 7446540 [TBL] [Abstract][Full Text] [Related]
38. Patient package insert--legal perspective. Hirsh HL Leg Med Q; 1979; 3(1):31-4. PubMed ID: 10245004 [No Abstract] [Full Text] [Related]
39. Progestational drug products for human use; requirements for labeling directed to the patient. Food and Drug Administration, HHS. Final rule. Fed Regist; 1999 Nov; 64(220):62110-2. PubMed ID: 11010691 [TBL] [Abstract][Full Text] [Related]
40. Readability--its applicability to education of patients by pharmacy. Adams RC; Smith TP; Metts JK; Ross JW Hosp Pharm; 1979 Nov; 14(11):654-6, 659-60, 662. PubMed ID: 10244957 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]